期刊
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
卷 33, 期 1, 页码 1064-1073出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2018.1482285
关键词
Nitroimidazoles; carbonic anhydrase IX; zebrafish; Xenopus oocytes; in vivo inhibition
资金
- Sigrid Juselius Foundation
- Finnish Cultural Foundation
- Academy of Finland
- Orion-Farmos Foundation
- Tampere Tuberculosis Foundation
Carbonic anhydrase (CA) IX is a hypoxia inducible enzyme that is highly expressed in solid tumours. Therefore, it has been considered as an anticancer target using specific chemical inhibitors. The nitroimidazoles DTP338 and DTP348 have been shown to inhibit CA IX in nanomolar range in vitro and reduce extracellular acidification in hypoxia, and impair tumour growth. We screened these compounds for toxicity using zebrafish embryos and measured their in vivo effects on human CA IX in Xenopus oocytes. In the toxicity screening, the LD50 for both compounds was 3.5mM. Neither compound showed apparent toxicity below 300 mu M concentration. Above this concentration, both compounds altered the movement of zebrafish larvae. The IC50 was 0.14 +/- 0.02 mu M for DTP338 and 19.26 +/- 1.97 mu M for DTP348, suggesting that these compounds efficiently inhibit CA IX in vivo. Our results suggest that these compounds can be developed as drugs for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据